Key result
Takotsubo syndrome is linked to markedly elevated subacute cytokine and innate immune proteins versus STEMI.
Why the study?
Does proximity extension assay-based plasma proteomics identify temporal differences in circulating protein abundance between women with Takotsubo syndrome and women with STEMI across acute, subacute, and late phases?
Observational (n=72)
Does proximity extension assay-based plasma proteomics identify temporal differences in circulating protein abundance between women with Takotsubo syndrome and women with STEMI across acute, subacute, and late phases?
The subacute phase after presentation is the key window for distinguishing plasma proteomic profiles—specifically immune and inflammatory signaling pathways—between women with Takotsubo syndrome and those with STEMI.
Answers are grounded in this paper and cite their sources.
Subacute proteomic profiling may differentiate takotsubo syndrome from myocardial infarction in women; hypothesis-generating for immunological pathways and requires validation.
BACKGROUND: Takotsubo syndrome (TS) and ST-elevation myocardial infarction (STEMI) present with similar acute clinical features but arise from distinct pathophysiological mechanisms. We aimed to characterize temporal differences in circulating plasma between TS and STEMI using proximity extension assay-based proteomics. To minimize confounding by sex-related differences in protein expression, we restricted analyses to women. METHODS: Plasma samples were collected from 38 women with TS and 34 women with STEMI at the acute, subacute, and late phase following presentation. Protein abundance was quantified using the Olink proximity extension assay platform. Differential abundance between TS and STEMI was assessed using linear regression models adjusted for age and sampling day, with false discovery rate correction. Pathway over-representation analysis was performed on differentially abundant proteins. RESULTS: Few proteins differed between TS and STEMI at the acute and late time points. In contrast, the subacute phase demonstrated a markedly larger number of proteins increased in TS relative to STEMI. Pathway enrichment analysis of proteins increased in TS revealed representation of cytokine and interleukin signaling, innate immune system pathways, and receptor tyrosine kinase-mediated signal transduction. No coherent pathway signature was observed among proteins increased in STEMI at this time point. CONCLUSION: These findings highlight the subacute phase as a key interval for distinguishing plasma protein profiles between these clinically overlapping syndromes.
No takes yet. Share an insight, caveat, or question.
Kakaei et al. (2026) conducted an observational in Takotsubo syndrome and ST-elevation myocardial infarction (n=72). Takotsubo syndrome vs. ST-elevation myocardial infarction was evaluated on Differential plasma protein abundance across acute, subacute, and late phases. Takotsubo syndrome in 38 women vs STEMI in 34 women showed markedly increased subacute plasma proteins enriched in cytokine, innate immune, and receptor tyrosine kinase pathways.
Synapse has enriched 10 related papers. Consider them for comparative context: